Google Alert - lose weight

	lose weight As-it-happens update ⋅ February 24, 2026
	NEWS
	Novo's triple G candidate drives 20% weight loss in phase 2 - Fierce Biotech Fierce Biotech Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks, illuminating a ... Flag as irrelevant
	Mounjaro: GP incentive to prescribe weight loss jabs won't tackle rollout problems, experts warn The BMJ GPs will be "incentivised" to refer eligible patients to weight loss programmes and to prescribe weight loss jabs such as tirzepatide (Mounjaro) as ... Flag as irrelevant
	Novo to cut Ozempic and Wegovy prices amid intense competition - USA Today USA Today Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, 2027. Flag as irrelevant
	Novo Nordisk cuts sticker price of weight-loss drugs - Axios Axios Novo Nordisk on Tuesday said it's lowering the list price for its blockbuster weight-loss and diabetes drugs by as much as half starting next year ... Flag as irrelevant
	The Benefits and Risks of a Post-Workout Sauna - Men's Health Men's Health Nitric Oxide Supplements: Do They Help Fitness? How to Use Weight Training for Weight Loss · How Exercise Really Affects Your Testosterone · 5 Ways to ... Flag as irrelevant
	Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and ... PR Newswire ... weight-related medical problems to lose weight and keep the weight off. Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback